In the preclinical setting, a recent study characterized the inflammation-induced neurological dysfunction by radiotherapy to tumor bearing hind flank of mice in combination with anti-CTLA4 blockade in preclinical models18. The gene discussed is CTLA4; the disease is neoplasm.